University of Antwerp

Running trials

• Recruiting

  A Phase 2 Platform Study to Evaluate Therapies for Inflammatory Bowel Disease

  2025-522001-38-00· Phase 2· Mirador Therapeutics Inc.· Source

• Recruiting

  A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer

  NCT07221357· Phase 2/3· Bristol-Myers Squibb· Source

• Recruiting

  Improvement Through Movement - Balance Control and Somatosensory Function in People With Diabetes Mellitus Type 2

  NCT07786194· Universiteit Antwerpen· Source

• Not yet recruiting

  Assessment and Treat Neglect Patients With a VR Application

  NCT06999473· Universiteit Antwerpen· Source

• Recruiting

  A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's Disease

  NCT06976268· Phase 2/3· Biohaven Therapeutics Ltd.· Source

• Enrolling by invitation

  Personalised Treatment for OSA

  NCT06915077· University Hospital, Antwerp· Source

• Active, not recruiting

  A Phase I/IIa Study of Roginolisib in combination with dostarlimab with or without docetaxel in Advanced NSCLC (PULMO-01)

  2024-517741-14-00· Phase 1/2· iOnctura SA· Source

• Active, not recruiting

  Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections

  NCT06945627· Sara Poletti· Source

• Recruiting

  INSTA-MD: INflammation-based Stratification for immune-Targeted Augmentation in Major Depressive disorder

  NCT05644301· Phase 3· University Of Antwerp· Source

• Active, not recruiting

  Cervical Cancer Screening Based on First-void Urine Self-sampling to Reach un(Der)-Screened Women: ScreenUrSelf Trial

  NCT05996783· Universiteit Antwerpen· Source

• Recruiting

  Prevention of Post-TIPS Hepatic Encephalopathy by Administration of Rifaximin and Lactulose

  NCT04073290· Phase 4· Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)· Source

• Recruiting

  High-Risk Neuroblastoma Study 2 of SIOP-Europa-Neuroblastoma (SIOPEN)

  NCT04221035· Phase 3· Gustave Roussy, Cancer Campus, Grand Paris· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Childhood cancers1 recruiting
• Colorectal cancer1 recruiting
• Depression1 recruiting
• High blood pressure1 recruiting
• Liver cirrhosis1 recruiting
• Neuroblastoma1 recruiting
• Obstructive sleep apnoea1 recruiting
• Parkinson disease1 recruiting
• Stroke1 recruiting
• Type 2 diabetes1 recruiting
• Ulcerative colitis1 recruiting

Closed trials

• Completed

  Exploring Physiotherapist's Knowledge, Attitudes, Beliefs and Clinical Decision-making Regarding Physical Activity in Chronic Pain Management.

  NCT06605729· Universiteit Antwerpen· Source

• Active, not recruiting

  A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer

  NCT05565378· Phase 2· GlaxoSmithKline· Source

• Completed

  Gait in Rare Diseases

  NCT05161494· Universiteit Antwerpen· Source

• Completed

  Open Label Extension of 2 mg/kg Pegunigalsidase Alfa (PRX-102) Every 4 Weeks in Adult Fabry Disease Patients

  NCT03614234· Phase 3· Chiesi Farmaceutici S.p.A.· Source

Conditions

Diseases this institution publishes on or runs trials for.

• Fatty liver disease (MASLD/MASH)25 works · 0 trials
• Cervical cancer23 works · 1 trial
• Obstructive sleep apnoea22 works · 1 trial
• Hearing loss15 works · 0 trials
• Frontotemporal dementia13 works · 0 trials
• Head and neck cancer11 works · 0 trials
• Cerebral palsy10 works · 0 trials
• Down syndrome7 works · 0 trials
• Huntington's disease7 works · 0 trials
• Keratoconus6 works · 0 trials
• Mesothelioma4 works · 0 trials
• Barrett's oesophagus4 works · 0 trials
• Lewy body dementia4 works · 0 trials
• Charcot-Marie-Tooth disease3 works · 0 trials
• Primary biliary cholangitis3 works · 0 trials